Categories: HealthcareNews

INVESTOR GROUP SERVICES (IGS) APPOINTS MATT UMSCHEID AS CEO

BOSTON, May 28, 2025 /PRNewswire/ — Investor Group Services (IGS), a leading private equity consulting firm specializing in value creation, portfolio optimization, and due diligence advisory, is pleased to announce that Matt Umscheid has been appointed Chief Executive Officer (CEO).

Most recently, he served as CEO at Nuvem, a pharmacy services and technology company, where he led a significant transformation effort positioning the business for long-term, sustainable growth. Prior to this, Matt was the CEO at Envysion, a Video SaaS company, which was acquired by Motorola Solutions. He also held multiple senior leadership roles at LogistiCare and Providence Service Corporation (now known as Modivcare), a diversified healthcare and human services company. Matt spent the first 12 years of his career in consulting at Arthur D. Little and then L.E.K. Consulting, advising large corporate organizations, middle market companies and private equity firms on strategy, operations, and M&A transactions. He then spent nearly nine years at Parthenon Capital as a senior resource team member working closely with investors and CEOs on due diligence and post-investment value creation initiatives across Parthenon portfolio companies.

“I am thrilled to join IGS during this period of strong momentum and opportunity,” said Matt. “With an outstanding team, a reputation for excellence, and a clear focus on creating value for investors and management teams, I see enormous opportunity to build on our strengths and expand our impact.”

Founders Mindy Berman and Rob Lordi shared their enthusiasm. “Welcoming Matt marks an exciting new chapter for IGS,” said Mindy Berman. “His strategic leadership and depth of experience make him the right person to lead the firm into its next stage.” Rob Lordi added, “We’re excited to partner with Matt to accelerate IGS’ growth and continue building a market-leading platform.”

“We enthusiastically welcome Matt as the new CEO of IGS,” said Rob Zielinski, Managing Partner at Interlock Equity. “Matt brings a strong track record of leadership, a proven ability to drive growth, and a deep alignment with the company’s culture. We are confident he will create lasting value for IGS’ clients, employees, and stakeholders.”

About Investor Group Services (IGS)

IGS provides commercial due diligence, portfolio value creation, and strategic advisory services to private equity firms and their portfolio companies. These groups rely on IGS for strategic insights, market intelligence, and research prowess to inform critical investment and strategic decisions.

For additional information, please visit www.igsinsights.com.

About Interlock Equity

Interlock Equity is a Los Angeles-based private equity firm dedicated to partnering with leadership teams of knowledge-based businesses. Since its founding in 2021, Interlock has built a strong track record of supporting passionate entrepreneurs whose companies provide mission-critical services aligned with long-term growth trends. Working collaboratively with management teams, Interlock delivers strategic and operational guidance to help businesses navigate the complexities and opportunities of rapid expansion.

For additional information, please visit www.interlockequity.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-group-services-igs-appoints-matt-umscheid-as-ceo-302467170.html

SOURCE Investor Group Services

Staff

Recent Posts

BioSonic Bloom: What Published Research Says About 528 Hz and 432 Hz Audio Frequency Programs

An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for…

6 hours ago

Best TRT Injection for 2026: Fridays Lists Prescription Testosterone in Injectable and Oral Formats as Men Compare Telehealth Hormone Options

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research…

6 hours ago

How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ

Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details –…

6 hours ago

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand

Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before…

6 hours ago

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

1 day ago